Doerfler Douglas's Form 4 filing
Maxcyte, Inc. (MXCT) · filed Dec 1, 2023
- Accession no.
- 0001209191-23-057093
- Filed
- Dec 1, 2023, 5:14 PM ET
- Trade date
- Nov 29-Dec 1, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $127.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Doerfler DouglasCIK 0001874482 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Common Stock | MOption exerciseAcquired | +5,350 | $0.04 | +$214 | 338,547 | Direct | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −5,350 | $5.00 | −$26,750 | 333,197 | Direct | |
| Dec 1, 2023 | Common Stock | MOption exerciseAcquired | +20,200 | $0.04 | +$808 | 353,397 | Direct | |
| Dec 1, 2023 | Common Stock | SSaleDisposed | −20,200 | $5.00 | −$101,000 | 333,197 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Common Stock | MOption exerciseDisposed | −5,350 | $0.00 | $0 | 229,730 | Direct | |
| Dec 1, 2023 | Common Stock | MOption exerciseDisposed | −20,200 | $0.00 | $0 | 209,530 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.